Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells

Abstract PSA-RP2 is a variant transcript expressed from the PSA gene that is conserved in gorillas, chimpanzees and humans suggesting a particular relevance for this transcript in these primates. We demonstrated by qRT-PCR that PSA-RP2 is upregulated in prostate cancer compared with benign prostatic hyperplasia tissues. The PSA-RP2 protein was not detected in seminal fluid and was cytoplasmically localised but not secreted from LNCaP or transfected PC3 prostate cells, despite secretion from transfected Cos-7 and HEK293 kidney cell lines. PSA-RP2-transfected PC3 cells showed slightly decreased proliferation and increased migration towards PC3-conditioned medium that could suggest a functional role in prostate cancer.

[1]  Hans Lilja,et al.  Serum markers for prostate cancer: a rational approach to the literature. , 2008, European urology.

[2]  J. Clements,et al.  Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. , 2005, Endocrine-related cancer.

[3]  Z. Hall.  Cancer , 1906, The Hospital.

[4]  J Leinonen,et al.  Prostate-specific antigen. , 1999, Seminars in cancer biology.

[5]  N. Heuzé-Vourc’h,et al.  Characterization of PSA-RP2, a protein related to prostate-specific antigen and encoded by alternative hKLK3 transcripts. , 2001, European journal of biochemistry.

[6]  E. Diamandis,et al.  Emerging biomarkers for the diagnosis and prognosis of prostate cancer. , 2008, Clinical chemistry.

[7]  J. Clements,et al.  The Tissue Kallikrein Family of Serine Proteases: Functional Roles in Human Disease and Potential as Clinical Biomarkers , 2004, Critical reviews in clinical laboratory sciences.

[8]  W. Catalona,et al.  Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer. , 2004, Clinical chemistry.

[9]  L. Mintz,et al.  Unusual Alternative Splicing within the Human Kallikrein Genes KLK2 and KLK3 Gives Rise to Novel Prostate-specific Proteins* , 2002, The Journal of Biological Chemistry.

[10]  G. Yousef,et al.  A survey of alternative transcripts of human tissue kallikrein genes. , 2005, Biochimica et biophysica acta.

[11]  J. Holaday,et al.  Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivo , 2003, The Prostate.

[12]  E. Diamandis,et al.  The emerging roles of human tissue kallikreins in cancer , 2004, Nature Reviews Cancer.

[13]  J. Clements,et al.  Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function? , 2006, Biological chemistry.

[14]  Leonard S Marks,et al.  Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease. , 2003, Clinical chemistry.

[15]  Å. Lundwall,et al.  Kallikrein-related peptidases , 2008, Cellular and Molecular Life Sciences.

[16]  J. Clements,et al.  Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer , 2007, The Prostate.

[17]  N. Heuzé-Vourc’h,et al.  Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen). , 2003, European journal of biochemistry.

[18]  D. Chan,et al.  Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%. , 2004, Urology.

[19]  P. Riegman,et al.  Molecular cloning and characterization of novel prostate antigen cDNA's. , 1988, Biochemical and biophysical research communications.

[20]  J. Phang,et al.  Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. , 2001, Carcinogenesis.

[21]  H. Samaratunga,et al.  Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. , 2005, Endocrine-related cancer.

[22]  Kurt Miller,et al.  New markers and multivariate models for prostate cancer detection. , 2009, Anticancer research.

[23]  Bruce T Lahn,et al.  Rate of molecular evolution of the seminal protein gene SEMG2 correlates with levels of female promiscuity , 2004, Nature Genetics.